SP1 and Huntington disease: In the case of the two anthracyclines tested in pharmacological therapy of HD, mithramycin and chromomycin, binding to the minor groove of DNA promotes the displacement of GC-rich binding regulators, such as the Sp1 family members, with important consequences on restoring the imbalance between histone methylation and acetylation [76].